New Strong Buy Stocks for July 21st
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Entrada Therapeutics, Inc. TRDA: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 47.5% over the last 60 days.
Entrada Therapeutics, Inc. Price and Consensus
Entrada Therapeutics, Inc. price-consensus-chart | Entrada Therapeutics, Inc. Quote
Open Lending Corporation LPRO: This company which provides lending enablement and risk analytics solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
Open Lending Corporation Price and Consensus
Open Lending Corporation price-consensus-chart | Open Lending Corporation Quote
The Bancorp, Inc. TBBK: This financial holding company for The Bancorp Bank has seen the Zacks Consensus Estimate for its current year earnings increasing 0.3% over the last 60 days.
The Bancorp, Inc. Price and Consensus
The Bancorp, Inc. price-consensus-chart | The Bancorp, Inc. Quote
BM Technologies, Inc. BMTX: This financial technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 34.1% over the last 60 days.
BM Technologies, Inc. Price and Consensus
BM Technologies, Inc. price-consensus-chart | BM Technologies, Inc. Quote
Motus GI Holdings, Inc. MOTS: This medical technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 32.5% over the last 60 days.
Motus GI Holdings, Inc. Price and Consensus
Motus GI Holdings, Inc. price-consensus-chart | Motus GI Holdings, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Bancorp, Inc. (TBBK) : Free Stock Analysis Report
Motus GI Holdings, Inc. (MOTS) : Free Stock Analysis Report
Open Lending Corporation (LPRO) : Free Stock Analysis Report
BM Technologies, Inc. (BMTX) : Free Stock Analysis Report
Entrada Therapeutics, Inc. (TRDA) : Free Stock Analysis Report
